台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    59.7
  • 漲跌
    ▼0.3
  • 漲幅
    -0.50%
  • 成交量
    38
  • 產業
    上櫃 文化創意指數
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智基 (6294)籌碼相關-元大-四維 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-四維 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/1700.00260.6060.70-291-2.19%
2024/12/1600.00161.0062.10-190-1.10%
2024/12/09166.9000.0066.401941.06%
2024/11/21162.00163.3063.300940.00%
2024/11/20166.66165.3064.400910.04%
2024/11/141.171.61170.5069.700.11020.05%
2024/11/130.177.9000.0077.400.1970.05%
2024/11/12186.01386.0186.00-290-2.22%
2024/09/23196.6000.0096.4011380.72%
2024/09/1800.00296.6096.20-2139-1.43%
2024/09/09098.5000.0098.1001370.01%
2024/09/06099.8000.0099.5001370.01%
2024/08/2900.001101.00101.00-1138-0.72%
2024/08/2800.002100.50100.50-2138-1.44%
2024/08/231101.5000.00102.0011360.73%
2024/08/211103.5000.00102.0011350.74%
2024/08/203105.8300.00104.5031332.24%
2024/08/1900.003107.00106.00-3130-2.30%
2024/08/152103.0000.00102.5021141.74%
2024/08/1400.002102.50104.50-2112-1.77%
2024/08/132102.250104.00101.5021091.81%
2024/08/123100.331102.50102.502992.01%
2024/08/09199.021100.00100.500930.02%
2024/08/0700.004107.99108.00-497-4.11%
2024/07/2300.000.1101.00101.50-0.190-0.10%
2024/07/1600.002101.50102.00-291-2.18%
2024/07/1500.003101.50101.50-392-3.24%
2024/07/1100.001101.00101.50-194-1.06%
2024/07/0900.003101.00101.50-3101-2.94%
2024/07/041102.0000.00102.5011280.78%
2024/06/130101.0000.00100.5001520.01%
2024/05/226103.5000.00103.0061573.81%
2024/05/162106.5000.00107.0021501.33%
2024/05/1500.000.2103.00104.00-0.2148-0.10%
2024/05/141.6101.3600.00102.001.61441.07%
2024/05/130107.0000.00107.0001270.02%
2024/05/020118.0000.00118.0001160.01%
2024/04/230.1117.5000.00117.500.11150.07%
2024/04/110.1119.2500.00119.500.11010.06%
2024/04/1000.000127.00127.00095-0.02%
2024/03/290121.5000.00122.000680.04%
2024/03/281122.0000.00122.501671.49%
2024/03/181122.5000.00124.001511.95%
2024/03/1500.001120.50121.50-147-2.12%
2024/03/1100.001114.50114.50-136-2.77%
2024/02/220112.5000.00112.000320.06%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音